Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Medipattern Corporation V.MKI

TSXV:MKI - Post Discussion

The Medipattern Corporation > Still waiting patiently
View:
Post by littlerichard48 on Mar 19, 2012 3:25pm

Still waiting patiently

Comment by xsnrg on Mar 19, 2012 3:48pm
You shall be rewarded soon, as you can see from the posts we are headed to $11.33 so you can afford to be a little patient for a 6294% return :)
Comment by littlerichard48 on Mar 19, 2012 4:21pm
N
Comment by littlerichard48 on Mar 19, 2012 4:33pm
Comment by littlerichard48 on Mar 19, 2012 4:56pm
Sorry about that, having some trouble with my I phone.  I'm very much hoping to see to some positive news in the near future with regards to a National Release of Vascular Visualize and also some very promising news with regards to a new code for B CAD.  B CAD is much to good to just throw away and I'm sure that they have been working with the AMA to get a reimbursement code that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities